A Study of Felzartamab in Participants With Lupus Nephritis
Status:
Recruiting
Trial end date:
2025-05-01
Target enrollment:
Participant gender:
Summary
The goal of this clinical trial is to evaluate the safety and tolerability of felzartamab
plus standard of care in participants with refractory Lupus Nephritis (LN).